Endoscopic Sleeve Gastroplasty
8
4
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized Trial
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
ESG vs LSG: Short-term Nutritional Outcomes
Endoscopic Sleeve Gastroplasty for Morbid Obesity